Search research articles
Contact Us
Filters
Showing results (181-190 of 209) with videos related to
Page
of 21
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 6, 2024
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
Romina Salpini, Stefano D'Anna, Mohammad Alkhatib, et al.
International Journal of Antimicrobial Agents
|
October 3, 2006
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients
Carlo Torti, Giuseppe Lapadula, Maria Cristina Uccelli, et al.
Eclinicalmedicine
|
July 31, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation
Cristina Mussini, Andrea Giacomelli, Eugenia Quiros-Roldan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2005
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study
Carlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
Immunity, Inflammation and Disease
|
February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study
Francesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Frontiers in Aging
|
November 24, 2025
Correction: Health profiles of foreign-born elderly women with HIV in Italy
Stefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Frontiers in Aging
|
October 15, 2025
Health profiles of foreign-born elderly women with HIV in Italy
Stefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
Massimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
Annals of Internal Medicine
|
October 18, 2016
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study
Qing Wang, Andrea De Luca, Colette Smith, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 209) with videos related to
Sort By:
Page
of 21
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 6, 2024
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
Romina Salpini, Stefano D'Anna, Mohammad Alkhatib, et al.
International Journal of Antimicrobial Agents
|
October 3, 2006
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients
Carlo Torti, Giuseppe Lapadula, Maria Cristina Uccelli, et al.
Eclinicalmedicine
|
July 31, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation
Cristina Mussini, Andrea Giacomelli, Eugenia Quiros-Roldan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2005
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study
Carlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
Immunity, Inflammation and Disease
|
February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study
Francesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Frontiers in Aging
|
November 24, 2025
Correction: Health profiles of foreign-born elderly women with HIV in Italy
Stefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Frontiers in Aging
|
October 15, 2025
Health profiles of foreign-born elderly women with HIV in Italy
Stefania Arsuffi, Eugenia Quiros-Roldan, Fabio Riccardo Colombo, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
Massimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
Annals of Internal Medicine
|
October 18, 2016
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study
Qing Wang, Andrea De Luca, Colette Smith, et al.
Page
of 21